LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-edge Technology LUMICKS leverages Nobel Prize-winning technologies like optical tweezers and STED super-resolution to provide innovative solutions for biological force and interaction analysis, offering a unique selling point in the biotechnology research market.

Recent Product Launches With the recent launch of the C-Trap product line and C-Trap 'Dymo', LUMICKS has expanded its portfolio, presenting new sales opportunities to cater to researchers' needs at the molecular and cellular levels.

Strengthened Leadership Team The appointment of new key personnel like CEO Hugo de Wit and CFO Andre Nel indicates a strategic focus on leadership and operational excellence, potentially fostering greater market penetration and client engagement.

Financial Stability and Growth Having secured significant funding, including a recent $21.9M venture debt agreement with the European Investment Bank, LUMICKS demonstrates financial strength, enabling potential customers to entrust their research needs to a stable and growing partner.

Published Research Findings LUMICKS' research findings on improving chimeric antigen receptor T cell therapy for common blood cancers published in Translational Medicine highlight the company's commitment to advancing scientific knowledge, creating trust and interest among researchers in the field.

Similar companies to LUMICKS

LUMICKS Tech Stack

LUMICKS uses 8 technology products and services including LinkedIn Recruiter, Oracle, Web Components, and more. Explore LUMICKS's tech stack below.

  • LinkedIn Recruiter
    Applicant Tracking Systems
  • Oracle
    Enterprise
  • Web Components
    Miscellaneous
  • Material Design Lite
    UI Frameworks
  • LabVIEW
    Visualisation Software
  • ExactMetrics
    Web Platform Extensions
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

LUMICKS's Email Address Formats

LUMICKS uses at least 1 format(s):
LUMICKS Email FormatsExamplePercentage
F.Last@lumicks.comJ.Doe@lumicks.com
98%
First.Last@lumicks.comJohn.Doe@lumicks.com
1%
FirstMiddleLas@lumicks.comJohnMichaelDoe@lumicks.com
1%

Frequently Asked Questions

Where is LUMICKS's headquarters located?

Minus sign iconPlus sign icon
LUMICKS's main headquarters is located at Pilotenstraat 41 Amsterdam, North Holland 1059 CH NL. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is LUMICKS's official website and social media links?

Minus sign iconPlus sign icon
LUMICKS's official website is lumicks.com and has social profiles on LinkedIn.

How much revenue does LUMICKS generate?

Minus sign iconPlus sign icon
As of November 2024, LUMICKS's annual revenue reached $75M.

What is LUMICKS's SIC code NAICS code?

Minus sign iconPlus sign icon
LUMICKS's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LUMICKS have currently?

Minus sign iconPlus sign icon
As of November 2024, LUMICKS has approximately 201 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: H. D.Chief Technology Officer: M. D. G.Chief Legal Officer: B. T.. Explore LUMICKS's employee directory with LeadIQ.

What industry does LUMICKS belong to?

Minus sign iconPlus sign icon
LUMICKS operates in the Biotechnology Research industry.

What technology does LUMICKS use?

Minus sign iconPlus sign icon
LUMICKS's tech stack includes LinkedIn RecruiterOracleWeb ComponentsMaterial Design LiteLabVIEWExactMetricsNginxApache.

What is LUMICKS's email format?

Minus sign iconPlus sign icon
LUMICKS's email format typically follows the pattern of . Find more LUMICKS email formats with LeadIQ.

How much funding has LUMICKS raised to date?

Minus sign iconPlus sign icon
As of November 2024, LUMICKS has raised $22M in funding. The last funding round occurred on Oct 10, 2024 for $22M.

When was LUMICKS founded?

Minus sign iconPlus sign icon
LUMICKS was founded in 2014.
LUMICKS

LUMICKS

Biotechnology ResearchNorth Holland, Netherlands201-500 Employees

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. 

Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail.

Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.

Section iconCompany Overview

Headquarters
Pilotenstraat 41 Amsterdam, North Holland 1059 CH NL
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $22M

    LUMICKS has raised a total of $22M of funding over 6 rounds. Their latest funding round was raised on Oct 10, 2024 in the amount of $22M.

  • $50M$100M

    LUMICKS's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $22M

    LUMICKS has raised a total of $22M of funding over 6 rounds. Their latest funding round was raised on Oct 10, 2024 in the amount of $22M.

  • $50M$100M

    LUMICKS's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.